Filter
1

Study of Trilaciclib and Lurbinectidin

for
Lung Cancer, Small-cell Lung Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05578326

Phase2, Recruiting

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

for
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT05493566

Early_phase1, Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Solid Tumor, Adult,
Location: Boston MA, Hackensack NJ, Philadelphia PA, Fairfax VA,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06586957

Phase1, Recruiting

Cough Capture as a Portal Into the Lung

for
Lung Diseases, Lung Cancer, Lung Diseases, Obstructive,
Location: The Bronx NY
Sponsor: Albert Einstein College of Medicine

Sex: All

Age: 21+

Code: NCT05854563

Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

for
Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer),
Location: New York NY, Fairfax VA, Jacksonville FL, Cleveland OH,
Sponsor: Nuvectis Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05873686

Phase1, Recruiting

Interested in new lung cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

for
Lung Cancer, Radiation Fibrosis, Radiation Induced Lung Injury,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT04485286

Phase2, Recruiting

Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer

for
Extensive Stage Lung Small Cell Carcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT05244239

Phase1, Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase1, Recruiting

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

for
Non Small Cell Lung Cancer
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT04933903

Phase2, Recruiting

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

for
Metastatic Non Small Cell Lung Cancer
Location: New York NY, Montreal, Camden NJ, Richmond VA,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT04614103

Phase2, Recruiting

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

for
Non-small Cell Lung Cancer, Colorectal Cancer, Breast Cancer
Location: Skokie IL
Sponsor: Guardant Health, Inc.

Sex: All

Age: 18+

Code: NCT05935384

Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: New Haven CT, Lebanon NH, The Bronx NY, New York NY,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase3, Recruiting

Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data

for
Non-small Cell Lung Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 0+

Code: NCT06934343

Recruiting

Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy

for
Non-small Cell Lung Cancer, Radiation Toxicity
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sex: All

Age: 0+

Code: NCT03416972

Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

for
Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer,
Location: Houston TX, Beverly Hills CA, Santa Monica CA
Sponsor: Epkin

Sex: All

Age: 18+

Code: NCT06789172

Phase1, Recruiting

Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation

for
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06110572

Phase1, Phase2, Recruiting

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

for
Pulmonary Hemorrhage, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05053867

Phase3, Recruiting

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

for
Sarcoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06503146

Phase2, Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

for
Solid Tumors, ER+ Breast Cancer,
Location: Detroit MI, St Louis MO, Dallas TX, Salt Lake City UT
Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Sex: All

Age: 18+

Code: NCT05490472

Phase1, Phase2, Recruiting

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

for
Thoracic Cancers, Malignant Pleural Mesotheliomas NOS,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 70+

Code: NCT00242723

Recruiting